CLINICAL_TRIALS ClinicalTrials.gov record update

Phase IV Study Evaluating the Effect of Sitagliptin (Januvia™) on Beta-cell Function in Patients With Acute Myocardial Infarction or Unstable Angina Pectoris and Newly Detected Impaired Glucose Tolerance or Type 2 Diabetes.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00627744
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:49.501885+00:00
Published At: 2021-02-12T00:00:00+00:00
Record Updated At: 2021-02-12
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Myocardial Infarction", "Unstable Angina Pectoris", "Diabetes Mellitus", "Impaired Glucose Tolerance"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-02-12"
protocolSection.identificationModule.nctId: "NCT00627744"
protocolSection.identificationModule.officialTitle: "Phase IV Study Evaluating the Effect of Sitagliptin (Januvia\u2122) on Beta-cell Function in Patients With Acute Myocardial Infarction or Unstable Angina Pectoris and Newly Detected Impaired Glucose Tolerance or Type 2 Diabetes."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.